Related Experiment Video
Updated: Apr 30, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Tumor suppressor p53 induces miR-1915 processing to inhibit Bcl-2 in the apoptotic response to DNA damage
Kazuya Nakazawa1, Nurmaa Dashzeveg, Kiyotsugu Yoshida
1Department of Biochemistry, The Jikei University School of Medicine, Tokyo, Japan; Medical Research Institute, Tokyo Medical and Dental University, Japan.
Abstract:
The antiapoptotic protein Bcl-2 is overexpressed in human cancers, and confers resistance to antitumor agents in cancer cells. Bcl-2 is negatively regulated by the tumor suppressor p53 in response to DNA damage during apoptotic cell death. However, this molecular mechanism remains unclear. The available evidence indicates that miR-1915 represses Bcl-2 expression at the post-transcriptional level in human colorectal carcinoma cells, which is correlated with drug resistance. Here, we show that p53 controls miR-1915 expression in response to DNA damage. Induction of p53 affects the expression of precursor and mature, but not primary, miR-1915. Inhibition of miR-1915 abrogates downregulation of Bcl-2 expression following treatment with genotoxin. These findings demonstrate that p53 negatively regulates Bcl-2 expression by targeting miR-1915 processing from primary into precursor miRNA. Taken together, the findings of the current study reveal a novel mechanism whereby p53 negatively modulates Bcl-2 by controlling miR-1915.
Insights
The tumor suppressor p53 regulates miR-1915 processing in response to DNA damage. This mechanism controls the expression of the antiapoptotic protein Bcl-2, impacting cancer drug resistance.
Area of Science:
- Molecular biology
- Cancer research
- Gene regulation
Background:
- The antiapoptotic protein Bcl-2 is overexpressed in cancers, contributing to drug resistance.
- The tumor suppressor p53 normally downregulates Bcl-2 following DNA damage, but the mechanism is unclear.
- MicroRNA miR-1915 has been implicated in repressing Bcl-2 in colorectal cancer cells.
Purpose of the Study:
- To elucidate the molecular mechanism by which p53 negatively regulates Bcl-2 expression.
- To investigate the role of miR-1915 in the p53-mediated regulation of Bcl-2.
- To understand the link between p53, miR-1915, and cancer drug resistance.
Main Methods:
- Investigated p53's effect on miR-1915 expression in response to DNA damage.
- Analyzed the impact of p53 induction on different forms of miR-1915 (primary, precursor, mature).
- Assessed the effect of miR-1915 inhibition on Bcl-2 expression after genotoxic treatment.
Main Results:
- p53 induction in response to DNA damage influences the expression of precursor and mature miR-1915, but not primary miR-1915.
- Inhibiting miR-1915 prevents the downregulation of Bcl-2 expression following genotoxin treatment.
- p53 targets the processing of miR-1915 from its primary to precursor form.
Conclusions:
- p53 negatively regulates Bcl-2 expression through the modulation of miR-1915 processing.
- This novel pathway involving p53 and miR-1915 offers new insights into cancer drug resistance mechanisms.
- Understanding this regulatory axis could lead to improved therapeutic strategies for Bcl-2-overexpressing cancers.
More Related Videos
04:56Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
09:32Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
Published on: September 10, 2017
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
The Intrinsic Apoptotic Pathway
Negative Regulator Molecules
The Extrinsic Apoptotic Pathway